February 10, 2020 by Chain Drug Review
Chip Davis, Greg Drew, HDA, John Gray, The Healthcare Distribution Alliance (HDA) board of directors’ executive committee
Leading Headlines, Pharmacy
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) board of directors’ executive committee announced Monday the appointment of Chester “Chip” Davis, to the position of president and chief executive officer. Davis will join HDA during March of this year. He joins HDA coming from the Association for Accessible Medicines (AAM), the nation’s leading trade association
January 16, 2020 by John Gray
HDA, John Gray
January 6, 2020, Opinion
A new decade presents an opportunity for reflection. For Healthcare Distribution Alliance and our pharmaceutical distributor members, 2020 finds us reexamining the value our industry provides to the larger health care ecosystem while reassessing our priorities and anticipating what is around the corner. HDA captured the state of our industry, and what the future may
June 3, 2019 by Chain Drug Review
HDA, HDA (formerly known as the Healthcare Distribution Management Association), John Gray
Leading Headlines, Pharmacy
ARLINGTON, Va. — John Gray, president and chief executive officer of the Healthcare Distribution Alliance (HDA), announced on Monday his retirement from the organization. Gray will remain in his position until May 2, 2020. Gray, who has led HDA (formerly known as the Healthcare Distribution Management Association) since 2004, is credited with restructuring and streamlining
February 27, 2019 by Chain Drug Review
Drug Enforcement Administration’s (DEA) announcement of an enhanced data tool to support additional information sharing with pharmaceutical distributors and manufacturers:, Healthcare Distribution Alliance (HDA), John Gray
Leading Headlines, Pharmacy
ARLINGTON, Va. — Healthcare Distribution Alliance (HDA) president and chief executive officer John Gray issued the following statement in response to the Drug Enforcement Administration’s (DEA) announcement of an enhanced data tool to support additional information sharing with pharmaceutical distributors and manufacturers: “The DEA has taken an important step to enhance data transparency and address a
October 2, 2018 by Chain Drug Review
Greg Drew, Healthcare Distribution Alliance (HDA), John Gray, Robert Mauch
Leading Headlines, Pharmacy
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) announced today the election of Greg Drew, president of Value Drug Company, as chairman of HDA’s board of directors. Robert Mauch, executive vice president and group president at AmerisourceBergen Corporation, was elected vice chairman. The new leadership was announced at the HDA Annual Board and Membership Meeting. Drew,
September 19, 2018 by Chain Drug Review
Allied Against Opioid Abuse (AAOA), B. Douglas Hoey, Healthcare Distribution Alliance (HDA), John Gray, Marsha Millonig, National Alliance for State Pharmacy Associations (NASPA), National Community Pharmacists Association (NCPA), opiod epidemic
Leading Headlines, Pharmacy
ARLINGTON, Va. — Allied Against Opioid Abuse (AAOA), a national initiative to help prevent prescription opioid abuse and misuse through education, has created a pharmacy toolkit to equip pharmacists with resources to engage and educate patients about the safe use, storage and disposal of pain medicines. AAOA, along with its founding member, the Healthcare Distribution Alliance (HDA),
July 20, 2018 by Chain Drug Review
Drug Supply Chain Security Act (DSCSA)., Healthcare Distribution Alliance (HDA), John Gray
Leading Headlines, Pharmacy
ARLINGTON, Va. —Healthcare Distribution Alliance (HDA) president and chief executive officer John Gray released the following statement on the Department of Health and Human Services’ (HHS) recent directive to establish a Food and Drug Administration (FDA) work group to examine prescription drug importation policies: “HDA and the nation’s primary pharmaceutical distributors appreciate the Trump administration’s efforts
June 12, 2018 by Chain Drug Review
HDA Research Foundation, Healthcare Distribution Alliance, John Gray, Michael Conley, Novartis Pharmaceuticals Corp., Perry Fri
Leading Headlines, Pharmacy
COLORADO SPRINGS, Colo. — The HDA Research Foundation, the non-profit organization of the Healthcare Distribution Alliance (HDA), recognized Michael Conley of Novartis Pharmaceuticals Corp. with the 2018 Nexus Award for Lifetime Achievement at the HDA Business and Leadership Conference in Colorado Springs. The award is made possible through the support of Genentech, A Member of the
June 12, 2018 by Chain Drug Review
DIANA awards, Healthcare Distribution Alliance (HDA), John Gray
Leading Headlines, Pharmacy, Supplier News
COLORADO SPRINGS, Colo. — The Healthcare Distribution Alliance (HDA) honored pharmaceutical and consumer product manufacturers with the annual Distribution Industry Awards for Notable Achievements in Healthcare (DIANA). The awards were distributed at the HDA 2018 Business and Leadership Conference here. The DIANA Awards have been a symbol of excellence in the pharmaceutical supply chain since 1959.
June 11, 2018 by Chain Drug Review
Americares, Healthcare Distribution Alliance (HDA), Heather Bresch, John Gray, Michael Nyenhuis, mylan
Pharmacy, Supplier News
STAMFORD, Conn. – Americares, in partnership with the Healthcare Distribution Alliance (HDA), has presented its annual Power of Partnership Award to Mylan, in recognition of its outstanding commitment to increasing access to health care around the world. Mylan is among Americares most dedicated and longstanding supporters, providing pharmaceutical products for the organization’s health programs for people affected
April 18, 2018 by gwalden
DEA, drug distributors, HDA, John Gray, Opioid, prescription drug abuse
Pharmacy
ARLINGTON, Va. — Healthcare Distribution Alliance (HDA) president and CEO John Gray welcomed Attorney General Jeff Sessions’ announcement yesterday of a prescription drug information-sharing agreement between the Drug Enforcement Administration and the attorneys general of 46 states, the District of Columbia and Puerto Rico. Through this agreement, the DEA will share information from its Automation
November 2, 2017 by Chain Drug Review
B. Douglas Hoey, Chris Christie, Healthcare Distribution Alliance, John Gray, National Association of Chain Drug Stores, National Community Pharmacists Association, opioid abuse, opioid crisis, President Donald Trump, President's Commission on Combating Drug Addiction and the Opioid Crisis, Steve Anderson, video
Featured Articles, Leading Headlines, Pharmacy, Retail News, Videos
WASHINGTON — The President’s Commission on Combating Drug Addiction and the Opioid Crisis has issued its final report, which includes 56 recommendations to the Trump administration to help fight opioid abuse. President Donald Trump formed the presidential commission, chaired by New Jersey Gov. Chris Christie (R.), in a March 29 executive order as a way
October 26, 2017 by Chain Drug Review
Commission on Combating Drug Addiction and the Opioid Epidemic, CVS Health, Healthcare Distribution Alliance, John Gray, John Hammergren, Larry Merlo, McKesson, Melania Trump, opioid abuse crisis, opioid abuse epidemic, President Donald Trump, President's Commission on Combating Drug Addiction and the Opioid Crisis, Stefano Pessina, video, Walgreens Boots Alliance
Leading Headlines, Pharmacy, Retail News, Videos
WASHINGTON — Following through on pledge made this summer, President Donald Trump has formally declared the nation’s growing opioid abuse epidemic as a public health emergency. In a press conference at the White House on Thursday, the president and First Lady Melania Trump announced the action, which has drawn plaudits from public officials and pharmacy
September 26, 2017 by Chain Drug Review
2017 HDA Annual Board and Membership Meeting, Cardinal Health, H.D. Smith Holding Co., Healthcare Distribution Alliance, Henry Dale Smith Jr., John Gray, Jon Giacomin
Leading Headlines, Supplier News
ARLINGTON, Va. — Cardinal Health executive Jon Giacomin has been elected to a second term as chairman of the Healthcare Distribution Alliance board of directors. HDA announced the re-election of Giacomin, chief executive officer of Cardinal Health’s pharmaceutical segment, at the 2017 HDA Annual Board and Membership Meeting, held Sept. 24 to 27 in Laguna